Brawn Biotech shareholders and shareholding pattern
BSE: 530207Pharmaceuticals & BiotechnologySmall Cap
Last close ₹25.40₹0.00 (0.00%)
Share price at the BSE close on 21 Oct 2026. Previous close ₹25.40.
52-week range of traded prices to 21 Oct 2026
₹17.71Low, 16 Feb 2026₹25.70High, 6 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹7.62 Cr4,925th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 8.9
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 Jun 2026
- 1.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 22.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −12.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 Jun 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 4
Who owns Brawn Biotech, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters52.94%
- Indian institutions0.35%
- Individuals and others46.71%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Indian institutions
- Individuals and others
| Per cent | Dec 2016Filed 9 Jan | Mar 2017Filed 8 Apr | Jun 2017Filed 10 Jul | Sep 2017Filed 16 Oct | Dec 2017Filed 20 Jan | Mar 2018Filed 3 May | Jun 2018Filed 6 Aug | Sep 2018Filed 7 Oct | Dec 2018Filed 19 Jan | Mar 2019Filed 18 Apr | Jun 2019Filed 8 Aug | Sep 2019Filed 14 Oct | Dec 2019Filed 14 Jan | Mar 2020Filed 13 May | Jun 2020Filed 18 Jul | Sep 2020Filed 19 Oct | Dec 2020Filed 19 Jan | Mar 2021Filed 19 Apr | Jun 2021Filed 20 Jul | Sep 2021Filed 18 Oct | Dec 2021Filed 21 Jan | Mar 2022Filed 19 Apr | Jun 2022Filed 16 Jul | Sep 2022Filed 20 Oct | Dec 2022Filed 20 Jan | Mar 2023Filed 14 Apr | Jun 2023Filed 19 Jul | Sep 2023Filed 13 Oct | Dec 2023Filed 18 Jan | Mar 2024Filed 10 Apr | Jun 2024Filed 17 Jul | Sep 2024Filed 18 Oct | Dec 2024Filed 31 Jan | Mar 2025Filed 21 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 18 Oct | Dec 2025Filed 19 Jan | Mar 2026Filed 7 Apr | Jun 2026Filed 8 Jul | Sep 2026Filed 17 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 53.60% | 53.68% | 53.68% | 53.68% | 53.35% | 53.39% | 53.40% | 53.70% | 53.70% | 53.70% | 53.70% | 53.71% | 53.71% | 53.71% | 53.71% | 53.71% | 53.71% | 53.71% | 53.71% | 53.71% | 53.71% | 53.71% | 53.73% | 53.73% | 53.72% | 53.72% | 53.72% | 53.72% | 53.72% | 53.64% | 53.64% | 53.64% | 53.64% | 53.66% | 53.66% | 53.66% | 53.39% | 52.94% | 52.94% | 52.94% | |
| Indian promoters | 53.60% | 53.68% | 53.68% | 53.68% | 53.35% | 53.39% | 53.40% | 53.70% | 53.70% | 53.70% | 53.70% | 53.71% | 53.71% | 53.71% | 53.71% | 53.71% | 53.71% | 53.71% | 53.71% | 53.71% | 53.71% | 53.71% | 53.73% | 53.73% | 53.72% | 53.72% | 53.72% | 53.72% | 53.72% | 53.64% | 53.64% | 53.64% | 53.64% | 53.66% | 53.66% | 53.66% | 53.39% | 52.94% | 52.94% | 52.94% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 46.40% | 46.32% | 46.32% | 46.32% | 46.65% | 46.61% | 46.60% | 46.30% | 46.30% | 46.30% | 46.30% | 46.29% | 46.29% | 46.29% | 46.29% | 46.29% | 46.29% | 46.29% | 46.29% | 46.29% | 46.29% | 46.29% | 46.27% | 46.27% | 46.28% | 46.28% | 46.28% | 46.28% | 46.28% | 46.36% | 46.36% | 46.36% | 46.36% | 46.34% | 46.34% | 46.34% | 46.61% | 47.06% | 47.06% | 47.06% |
| Shares in issue | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 | 30,00,300 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100 |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Brawn Biotech promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is BRIJ RAJ GUPTA, 16.69%.Promoter buying and selling
| Holder | |||
|---|---|---|---|
| BRIJ RAJ GUPTAIndividuals and Hindu undivided families | 16.69% | 5,00,774 | 5,00,774 |
| SHASHI BALA GUPTAIndividuals and Hindu undivided families | 8.27% | 2,48,253 | 2,48,253 |
| NITIN GUPTAIndividuals and Hindu undivided families | 6.45% | 1,93,447 | 1,93,447 |
| BRIJ BALA GUPTAIndividuals and Hindu undivided families | 6.30% | 1,89,000 | 1,89,000 |
| ADARSH KUMAR GUPTAIndividuals and Hindu undivided families | 6.25% | 1,87,650 | 1,87,650 |
| ATUL GUPTAIndividuals and Hindu undivided families | 2.36% | 70,750 | 70,750 |
| A B PHARMA P LTDIndian companies, trusts and others | 2.27% | 68,100 | 0 |
| KAVITA GUPTAIndividuals and Hindu undivided families | 1.50% | 44,900 | 0 |
| Bhawna GoyalIndividuals and Hindu undivided families | 0.99% | 29,700 | 2,000 |
| MAMTA GUPTAIndividuals and Hindu undivided families | 0.44% | 13,200 | 0 |
| KUSH GUPTAIndividuals and Hindu undivided families | 0.43% | 13,050 | 13,050 |
| MAMTA GOELIndividuals and Hindu undivided families | 0.36% | 10,770 | 10,770 |
No promoter shares are reported as pledged. In demat is the part of the holding kept electronically; the rest is paper certificates.
Largest public holders of Brawn Biotech, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016Filed 9 Jan | Mar 2017Filed 8 Apr | Jun 2017Filed 10 Jul | Sep 2017Filed 16 Oct | Dec 2017Filed 20 Jan | Mar 2018Filed 3 May | Jun 2018Filed 6 Aug | Sep 2018Filed 7 Oct | Dec 2018Filed 19 Jan | Mar 2019Filed 18 Apr | Jun 2019Filed 8 Aug | Sep 2019Filed 14 Oct | Dec 2019Filed 14 Jan | Mar 2020Filed 13 May | Jun 2020Filed 18 Jul | Sep 2020Filed 19 Oct | Dec 2020Filed 19 Jan | Mar 2021Filed 19 Apr | Jun 2021Filed 20 Jul | Sep 2021Filed 18 Oct | Dec 2021Filed 21 Jan | Mar 2022Filed 19 Apr | Jun 2022Filed 16 Jul | Sep 2022Filed 20 Oct | Dec 2022Filed 20 Jan | Mar 2023Filed 14 Apr | Jun 2023Filed 19 Jul | Sep 2023Filed 13 Oct | Dec 2023Filed 18 Jan | Mar 2024Filed 10 Apr | Jun 2024Filed 17 Jul | Sep 2024Filed 18 Oct | Dec 2024Filed 31 Jan | Mar 2025Filed 21 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 18 Oct | Dec 2025Filed 19 Jan | Mar 2026Filed 7 Apr | Jun 2026Filed 8 Jul | Sep 2026Filed 17 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investor Education and Protection Fund (IEPF)Investor education fund | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 14.40% |
| DAKSHA KOTAKResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | – | 1.24% | 1.24% | 1.34% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% |
| INVESTOR EDUCATION AND PROTECTION FUND AUTHORITYInvestor education fund | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 11.14% | 11.14% | 13.35% | 14.42% | 14.42% | – |
| JAYSUKHLAL TRIBHOVANDAS DOSHIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.02% | – | – | – | – | – |
| INVESTOR EDUCATION AND PROTECTION FUND AUTHORInvestor education fund | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 10.49% | – | – | – | 11.14% | – | – | – | – | – | – |
| RAM BABU KANKANALAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.13% | – | – | – | – | – | – | – | – | – |
| DASARAJU AKHILESH VARMAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.05% | 1.09% | 1.09% | – | – | – | – | – | – | – | – | – |
| D SUBRAMANYAM RAJUResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | 1.13% | 1.35% | 1.50% | 1.21% | 1.18% | 1.18% | 1.11% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| AJIT KUMAROther non-institutions | – | – | – | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| DAKSHA VISHANJI KOTAKResident individuals, over ₹2 lakh at face value | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| KANUBHAI RAMESHBHAI PATELResident individuals, over ₹2 lakh at face value | 1.01% | 1.02% | – | 1.04% | 1.04% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.